ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 87 filers reported holding ANTARES PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $513,000 | +15.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | -2.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -16.5% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $545,000 | +6.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $514,000 | +3.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $499,000 | +47.6% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $338,000 | -1.7% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $344,000 | +16.6% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $295,000 | -49.8% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $588,000 | +40.7% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $418,000 | +1.7% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $411,000 | +8.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $379,000 | +11.5% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $340,000 | -19.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $420,000 | +30.0% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $323,000 | +17.5% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $275,000 | +10.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $249,000 | -38.5% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $405,000 | +0.5% | 125,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $403,000 | +13.5% | 125,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $355,000 | +22.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $291,000 | +20.2% | 125,000 | -13.2% | 0.00% | 0.0% |
| Q3 2016 | $242,000 | -27.3% | 144,000 | -47.6% | 0.00% | -33.3% |
| Q4 2015 | $333,000 | -28.8% | 275,000 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $468,000 | -18.2% | 275,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $572,000 | -23.2% | 275,000 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $745,000 | +5.4% | 275,000 | 0.0% | 0.01% | +20.0% |
| Q4 2014 | $707,000 | +39.4% | 275,000 | -0.7% | 0.01% | +25.0% |
| Q3 2014 | $507,000 | -31.5% | 277,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $740,000 | -26.8% | 277,000 | 0.0% | 0.01% | -33.3% |
| Q1 2014 | $1,011,000 | – | 277,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |